CARLSBAD, Calif.--(BUSINESS WIRE)--Lineage Cell Therapeutics, Inc. (NYSE American and TASE: LCTX), a clinical-stage biotechnology company developing novel allogeneic, or “off the shelf,” cell ...
A benchtop bioreactor system developed at Hannover Medical School can produce up to 40 million human immune cells per week from stem cells, according to a protocol published in Nature Protocols in ...
Some results have been hidden because they may be inaccessible to you
Show inaccessible results